Objective: To compare glycaemia control between glimepiride and metformin group with sitagliptin, glimepiride and metformin group in uncontrolled type 2 diabetic patient. Methods: This retrospective, randomized, clinical study was done in the diabetes research center. The number of the patient in this study was thirty-five patients. The patients examined individually in detail to check their general health in addition to the physical state. For all the patients, data had been collected and fasting plasma glucose level had been measured. Participants have been chosen by unresponsiveness of diabetic patient to single therapy of metformin or glimepiride in this trial. The patients were allocated into 2 groups. Group I include 14 patient given glimepiride, metformin and sitagliptin, while group II include 21 patients given glimepiride and metformin. Both Results: A statistical significant decrease was found in fasting plasma glucose level when compare before and after treatment regimen of sitagliptin, Glimepiride and Metformin group while no significant difference in fasting plasma glucose when comparing the triple therapy group (Sitagliptin, Glimepiride and Metformin) with the double therapy group (Glimepiride and Metformin) after thirty days of treatment. groups continue treatment for thirty days and statistical analyses include data collection was done. Conclusion: No significant difference was found between glimepiride and metformin therapy with sitagliptin, glimepiride and metformin therapy in uncontrolled type 2 diabetic patient.
Psoriasis is a chronic immuno-mediated inflammatory disease of 2.3% prevalence in Iraqi the etiology of the disease is not identified well. A wide variation in disease picture and response to treatment occur due to the complexity of the disease. The study includes 75 male and female people diagnosed with psoriasis. General data and treatment used have been analyzed. A questionnaire is prepared. The study shows that there were twenty-one patients aged between 15 and 24 years, thirty-three patients aged between 25 and 34 years, eight patients aged between 35 and 44 years, and thirteen patients were identified as being older than 44 years. The study shows that the distribution of patients is such that fifty-five percent are male, while forty-five percent are female. Betamethasone was most steroid used. Most of the patients repeat the treatment courses more than two times and most of the patients participated in the study use only one drug. In Conclusion both topical and systemic treatment is used and mostly steroids were the common used group.